Literature DB >> 27423269

Permissive XPR1 gammaretrovirus receptors in four mammalian species are functionally distinct in interference tests.

Qingping Liu1, Yuhe Yan1, Christine A Kozak2.   

Abstract

Xenotropic/polytropic mouse leukemia viruses (X/P-MLVs) use the XPR1 gammaretrovirus receptor for entry. X/P-MLV host range is defined by usage of naturally occurring restrictive XPR1 receptors, and is governed by polymorphisms in the virus envelope glycoprotein and in XPR1. Here, we examined receptors of four mammalian species permissive to all X/P-MLVs (Mus dunni, human, rabbit, mink). Interference assays showed the four to be functionally distinct. Preinfection with X-MLVs consistently blocked all nine XPR1-dependent viruses, while preinfection with P-MLVs and wild mouse X/P-MLVs produced distinctive interference patterns in the four cells. These patterns indicate shared usage of independent, but not always fully functional, receptor sites. XPR1 sequence comparisons identified candidate sites in receptor-determining regions that correlate with some interference patterns. The evolutionary record suggests that the X/P-MLV tropism variants evolved to adapt to host receptor polymorphisms, to circumvent blocks by competing viruses or to avoid host-encoded envelope glycoproteins acquired for defense. Published by Elsevier Inc.

Entities:  

Keywords:  Gammaretrovirus interference; Mouse gammaretroviruses; Mouse leukemia viruses; XPR1 retrovirus receptor

Mesh:

Substances:

Year:  2016        PMID: 27423269      PMCID: PMC5026577          DOI: 10.1016/j.virol.2016.06.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  Primate gammaretroviruses require an ancillary factor not required for murine gammaretroviruses to infect BHK cells.

Authors:  Wenqin Xu; Maribeth V Eiden
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution.

Authors:  D Fass; R A Davey; C A Hamson; P S Kim; J M Cunningham; J M Berger
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

3.  Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells.

Authors:  A Rein
Journal:  Virology       Date:  1982-07-15       Impact factor: 3.616

4.  Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection.

Authors:  R H Bassin; S Ruscetti; I Ali; D K Haapala; A Rein
Journal:  Virology       Date:  1982-11       Impact factor: 3.616

5.  Structure and distribution of endogenous nonecotropic murine leukemia viruses in wild mice.

Authors:  K Tomonaga; J M Coffin
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Common inbred strains of the laboratory mouse that are susceptible to infection by mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV.

Authors:  Surendranath Baliji; Qingping Liu; Christine A Kozak
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

7.  Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses.

Authors:  M Marin; C S Tailor; A Nouri; S L Kozak; D Kabat
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class.

Authors:  J W Hartley; W P Rowe
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

9.  Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses.

Authors:  C S Tailor; A Nouri; C G Lee; C Kozak; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

10.  Host Susceptibility to endogenous viruses: defective, glycoprotein-expressing proviruses interfere with infections.

Authors:  H L Robinson; S M Astrin; A M Senior; F H Salazar
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.